JP2012512645A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512645A5
JP2012512645A5 JP2011541497A JP2011541497A JP2012512645A5 JP 2012512645 A5 JP2012512645 A5 JP 2012512645A5 JP 2011541497 A JP2011541497 A JP 2011541497A JP 2011541497 A JP2011541497 A JP 2011541497A JP 2012512645 A5 JP2012512645 A5 JP 2012512645A5
Authority
JP
Japan
Prior art keywords
seq
factor
protein
replaced
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011541497A
Other languages
English (en)
Japanese (ja)
Other versions
JP5833448B2 (ja
JP2012512645A (ja
Filing date
Publication date
Priority claimed from EP08305990A external-priority patent/EP2199387A1/en
Application filed filed Critical
Priority claimed from PCT/EP2009/067632 external-priority patent/WO2010070137A1/en
Publication of JP2012512645A publication Critical patent/JP2012512645A/ja
Publication of JP2012512645A5 publication Critical patent/JP2012512645A5/ja
Application granted granted Critical
Publication of JP5833448B2 publication Critical patent/JP5833448B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011541497A 2008-12-19 2009-12-21 セリンプロテアーゼ誘導体および血液凝固疾患の予防または処置における使用 Expired - Fee Related JP5833448B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP08305990.7 2008-12-19
EP08305990A EP2199387A1 (en) 2008-12-19 2008-12-19 Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
EP09305349 2009-04-23
EP09305349.4 2009-04-23
US22296009P 2009-07-03 2009-07-03
US61/222960 2009-07-03
PCT/EP2009/067632 WO2010070137A1 (en) 2008-12-19 2009-12-21 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders

Publications (3)

Publication Number Publication Date
JP2012512645A JP2012512645A (ja) 2012-06-07
JP2012512645A5 true JP2012512645A5 (cg-RX-API-DMAC7.html) 2013-02-14
JP5833448B2 JP5833448B2 (ja) 2015-12-16

Family

ID=41718355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011541497A Expired - Fee Related JP5833448B2 (ja) 2008-12-19 2009-12-21 セリンプロテアーゼ誘導体および血液凝固疾患の予防または処置における使用

Country Status (9)

Country Link
US (3) US8436144B2 (cg-RX-API-DMAC7.html)
EP (1) EP2358874B1 (cg-RX-API-DMAC7.html)
JP (1) JP5833448B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110114587A (cg-RX-API-DMAC7.html)
CN (2) CN104262479A (cg-RX-API-DMAC7.html)
AU (1) AU2009329493B2 (cg-RX-API-DMAC7.html)
CA (1) CA2747065A1 (cg-RX-API-DMAC7.html)
ES (1) ES2629099T3 (cg-RX-API-DMAC7.html)
WO (1) WO2010070137A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX336958B (es) 2005-11-15 2016-02-05 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
EP3824902A1 (en) 2007-09-28 2021-05-26 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same
CN102316893B (zh) 2008-11-14 2015-02-18 博尔托拉制药公司 因子Xa抑制剂的解毒剂及其与血液凝固剂组合使用的方法
CN104262479A (zh) * 2008-12-19 2015-01-07 国家健康与医学研究院 丝氨酸蛋白酶衍生物及其在凝血功能障碍的预防或治疗中的用途
LT3604510T (lt) 2009-03-30 2025-07-10 Alexion Pharmaceuticals, Inc. Faktoriaus xa inhibitorius neutralizuojančios medžiagos ir jų naudojimo būdai
PT2453910T (pt) 2009-07-15 2016-12-07 Portola Pharm Inc Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
WO2013049804A1 (en) * 2011-09-30 2013-04-04 The Children's Hospital Of Philadelphia Compositions and methods for modulating hemostasis
IN2015DN01404A (cg-RX-API-DMAC7.html) 2012-07-25 2015-07-03 Catalyst Biosciences Inc
HK1215196A1 (zh) 2013-01-31 2016-08-19 辉瑞公司 用於抵消因子xa抑制的组合物和方法
FR3001729B1 (fr) * 2013-02-04 2015-03-06 Lab Francais Du Fractionnement Mutants du facteur x
CN105008530A (zh) * 2013-03-12 2015-10-28 诺和诺德股份有限公司 凝血酶敏感性凝固因子x分子
SG11201601221XA (en) 2013-09-24 2016-04-28 Pfizer Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
EP3242936A1 (en) * 2015-01-07 2017-11-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Mutated factor x polypeptides and uses thereof for the treatment of haemophilia
WO2017017109A1 (en) * 2015-07-27 2017-02-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Mutated factor x polypeptides and uses thereof for the treatment of haemophilia

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4992373A (en) 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US4981952A (en) 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
MY110664A (en) 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
JP3866760B2 (ja) 1993-02-22 2007-01-10 ザ ロックフェラー ユニバーシティ 一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
FR2831170B1 (fr) * 2001-10-19 2004-03-19 Inst Nat Sante Rech Med Proteines c modifiees activables directement par la thrombine
FR2841904B1 (fr) * 2002-07-03 2004-08-20 Inst Nat Sante Rech Med Analogues de facteurs x clivables par la thrombine
WO2005007820A2 (en) 2003-07-08 2005-01-27 The Scripps Research Institute Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity
EP1769092A4 (en) 2004-06-29 2008-08-06 Europ Nickel Plc IMPROVED LIXIVIATION OF BASE METALS
US8828939B2 (en) * 2004-08-17 2014-09-09 Csl Behring Gmbh Modified vitamin K dependent polypeptides
EP1820508A1 (en) 2006-02-21 2007-08-22 CSL Behring GmbH Coagulation factor X polypeptides with modified activation properties
US8246856B2 (en) 2007-08-01 2012-08-21 Dow Global Technologies Llc Highly efficient process for manufacture of exfoliated graphene
CN104262479A (zh) * 2008-12-19 2015-01-07 国家健康与医学研究院 丝氨酸蛋白酶衍生物及其在凝血功能障碍的预防或治疗中的用途

Similar Documents

Publication Publication Date Title
JP2012512645A5 (cg-RX-API-DMAC7.html)
HRP20200871T1 (hr) Izmjenjeni rsv f proteini i postupci njihove uporabe
WO2013003045A3 (en) Procoagulant peptides and their derivatives and uses therefor
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
IN2012DN03368A (cg-RX-API-DMAC7.html)
JP2012082206A5 (cg-RX-API-DMAC7.html)
WO2009058662A3 (en) Glucagon antagonists
JP2018537087A5 (cg-RX-API-DMAC7.html)
KR20160036045A (ko) 프로테아제 저항성 펩타이드 리간드
JP2013502458A5 (cg-RX-API-DMAC7.html)
KR20140066157A (ko) Viii 인자 키메라 및 하이브리드 폴리펩타이드, 그리고 이들의 사용 방법
AR086078A1 (es) Proteinas de fusion y vacunas de combinacion
JP2012525836A5 (cg-RX-API-DMAC7.html)
JP2006149365A5 (cg-RX-API-DMAC7.html)
ES2736283T3 (es) Procedimientos para aislar hemoderivados a partir de un material hemoderivado empobrecido en proteína interalfainhibidora
JP2016501266A5 (cg-RX-API-DMAC7.html)
JP2015504052A5 (cg-RX-API-DMAC7.html)
JP2017000144A5 (cg-RX-API-DMAC7.html)
JP2015524403A5 (cg-RX-API-DMAC7.html)
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
MX2022002476A (es) Peptido q-er.
JP2016537981A5 (cg-RX-API-DMAC7.html)
JP2014504297A5 (cg-RX-API-DMAC7.html)
CN110563802B (zh) 一组含n-甲基化氨基酸及n端脂肪酸修饰的抗菌肽类似物及其合成方法和应用